K-Research Report issue

For profit Phase 2

Organization Overview

First Clinical Trial
2020
NCT04463251
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

K-Research | K-Research, LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

olokizumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 2)

Inflammation (Phase 2)

Myocardial Infarction (Phase 2)

ST Elevation Myocardial Infarction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1